...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Why worry about the Third Eye loan?

If Apabetalone ends up attaining a pipeline value like Biogen's Adumanucab (?)....which was somewhere around $16 billion USD, then 100K or 200K or even $1 or $2 million....who cares.  

Share
New Message
Please login to post a reply